We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oxford Biomedica Plc | LSE:OXB | London | Ordinary Share | GB00BDFBVT43 | ORD 50P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.50 | 0.69% | 220.00 | 218.00 | 219.50 | 223.00 | 212.50 | 219.00 | 275,208 | 16:35:02 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Medicinal Chems,botanicl Pds | 139.99M | -45.16M | -0.4676 | -4.67 | 211.03M |
TIDMOXB TIDMAV.
RNS Number : 1396A
Oxford Biomedica PLC
22 March 2017
Hot Features
Premium
For filings with the FCA
include the annex
For filings with issuer exclude
the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
-----------------------------------------------------------------------------------------------------------------
1. Identity of the issuer or Oxford Biomedica plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------------- ----------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-----------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
--------------------------------------------------------------------- ------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
--------------------------------------------------------------------- ------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
--------------------------------------------------------------------- ------------------------------------------
An event changing the breakdown of voting rights
--------------------------------------------------------------------- ------------------------------------------
Other (please
specify):
----------------------------------------------------------- -------- ------------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
------------------------------------------------------------- --------------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
Chase (GA Group) Nominees
Limited 202,248,884*
HSBC Global Custody Nominee
(UK) Limited 38,838,403*
State Street Nominees Limited
5,921,129*
*denotes direct interest
Chase (GA Group) Nominees
Limited 17,681,614
Chase Nominees Limited 7,709,254
Vidacos Nominees Limited 12,132,128
------------------------------------------------------------- --------------------------------------------------
5. Date of the transaction 16 March 2017
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------------- --------------------------------------------------
6. Date on which issuer 17 March 2017
notified:
------------------------------------------------------------- --------------------------------------------------
7. Threshold(s) that is/are 8% to 7% Change at Direct
crossed or Interest Level (Box 8A)
reached: (vi, vii)
------------------------------------------------------------- --------------------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after
of to the triggering the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
--------------- ----------------------------- --------------------------------------------------------------
Number Number Number Number of % of voting
of of of voting rights (x)
Shares Voting shares rights
Rights
--------------- ------------- -------------- ------------ ---------------------------- ------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
--------------- ------------- -------------- ------------ -------------- ------------ ------- ---------
Ordinary
Shares
GB00066458157 293,797,657* 293,797,657* 284,531,412 247,008,416 37,522,996 7.998% 1.215%
------------- -------------- ------------ -------------- ------------ ------- ---------
* Includes Right to Recall Loaned Shares (5,791,351)
--------------------------------------------------------------------------------------------------------------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
--------------- ------------- -------------- ------------------------------------------ ------------------
RIGHT TO 8,191,351*
RECALL
LOANED SHARES N/A N/A *DIRECT INTEREST 0.265%
--------------- ------------- -------------- ------------------------------------------ ------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
292,722,763 9.478%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
------------------------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited, with the following
chain of controlled undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Proxy Voting:
------------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
--------------------------------------------- -------------------------------
11. Number of voting rights proxy
holder will cease to hold:
--------------------------------------------- -------------------------------
12. Date on which proxy holder will
cease to hold voting rights:
--------------------------------------------- -------------------------------
13. Additional information: Figures are based the total
number of voting rights of
3,088,217,926 as per the
Company's Total Voting Rights
Announcement of 1 March 2017.
--------------------------------------------- -------------------------------
14. Contact name: Tim Watts
--------------------------------------------- -------------------------------
15. Contact telephone number: 01865 783000
--------------------------------------------- -------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUASBRBUAOUAR
(END) Dow Jones Newswires
March 22, 2017 03:01 ET (07:01 GMT)
1 Year Oxford Biomedica Chart |
1 Month Oxford Biomedica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
